(Q39340688)

11 September 2017

title

Hydralazine therapy in hypertensive patients with idiopathic systemic lupus erythematosus (English)

2 references

11 September 2017

https://api.crossref.org/works/10.1002/ART.1780180407

8 April 2022

1 reference

1 reference

https://api.crossref.org/works/10.1002/ART.1780180407

8 April 2022

1 reference

https://api.crossref.org/works/10.1002/ART.1780180407

systemic lupus erythematosus

8 April 2022

1 reference

Reza MJ

1

1 reference

11 September 2017

Dornfeld L

2

1 reference

11 September 2017

Goldberg LS

3

1 reference

11 September 2017

M. J. Reza

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A50845

8 April 2022

L. Dornfeld

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A50845

8 April 2022

L. S. Goldberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A50845

8 April 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=50845

8 April 2022

publication date

1 July 1975

1 reference

full work available at URL

11 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.1780180407

1 reference

https://api.crossref.org/works/10.1002/ART.1780180407

https://onlinelibrary.wiley.com/doi/full/10.1002/art.1780180407

8 April 2022

1 reference

https://api.crossref.org/works/10.1002/ART.1780180407

8 April 2022

published in

Arthritis & Rheumatology

1 reference

11 September 2017

Arthritis and Rheumatism

18

4

335–8

July 1975

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=50845

8 April 2022

volume

18

1 reference

11 September 2017

issue

4

1 reference

11 September 2017

page(s)

335-338

1 reference

Immune Responses to Hydralazine and Nuclear Antigens in Hydralazine-Induced Lupus Erythematosus

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FART.1780180407

Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis

21 January 2018

1

54

58

Perry

1973

1 reference

https://api.crossref.org/works/10.1002/ART.1780180407

ANTINUCLEAR FACTORS IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS

8 April 2022

3

63

100

Barnett

1965

1 reference

https://api.crossref.org/works/10.1002/ART.1780180407

Clinical and experimental studies on the hydralazine syndrome and its relationship to systemic lupus erythematosus

8 April 2022

7

46

1

Alarcon-Segovia

1967

1 reference

https://api.crossref.org/works/10.1002/ART.1780180407

LUPUS DIATHESIS AND THE HYDRALAZINE SYNDROME

8 April 2022

8

volume

272

0 references

Identifiers

1 reference

11 September 2017

1 reference